American HealthCare Capital is pleased to introduce a highly successful Neurology Practice and Infusion Center located in Houston, Texas. For decades, the practice has been treating patients with neurological diseases, including those which require IV infusion treatments. Specialties include migraine treatment, neck and low back pain, peripheral nerve and muscle disorders, multiple sclerosis and related disorders, inflammation of the central and peripheral nervous system, epilepsy treatment, and EMG testing.
The neurology practice is the primary source of income. Infusion Center income as a percentage of total gross revenue was 17% in 2020, 33% in 2021, and 38% in 2022. For the neurology practice, the payer mix is 38% Medicare, 61% Private Insurance, 1% Private Pay, and 0% Medicaid. Total gross revenues for 2020 were $1,984,359 with an Adjusted EBITDA of $610,734 (30.78%). In 2021, gross revenues grew to $2,283,526 with an Adjusted EBITDA of $895,521 (39.22%). In 2022, the neurology infusion center continued its impressive growth trend with $2,703,604 of gross revenues and $1,153,646 (42.67%) of Adjusted EBITDA. Notwithstanding the government’s review of drug prices, 2023 total gross revenues are reasonably expected to reach $3 million.
A full complement of support staff is expected to transition, and the physician owner is open to continue with the practice for a reasonable period after the sale.
Seller will consider competitive offers.
If you would like to learn more, please use the link on the right-hand side of the page to execute our NDA. You will need to copy the Listing Code (Example: TXMC1A) and Listing Title (Example: $1 Million Home Health Agency in Texas) from the summary above to complete the NDA.